<DOC>
	<DOCNO>NCT00072748</DOCNO>
	<brief_summary>This non-randomized , open-label , outpatient clinical trial design assess safety efficacy daily orally administer EKB-569 subject advance colorectal cancer . Patients must previously treat fluoropyrimidine ( 5-FU capecitabine ) either oxaliplatin irinotecan ( give concurrently separate regimen ) . The primary objective study assess clinical activity EKB-569 administer orally second-line late stage treatment subject advance colorectal cancer . Secondary objective include : - To evaluate safety EKB-569 - To explore additional clinical activity parameter - To explore subject survival - To evaluate pharmacokinetics EKB-569 - To assess subject report outcomes EKB-569 administer orally single-agent . Eligible subject take EKB-569 daily long progressive disease tolerate treatment .</brief_summary>
	<brief_title>Study Evaluating EKB-569 Advanced Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<criteria>Signed dated , institutional review board ( IRB ) independent ethic committee ( IEC ) approve informed consent form protocolspecific screening procedure Previous histologic diagnosis adenocarcinoma colon rectum EGFR expression immunohistochemical analysis ( must &gt; = 20 % positive tumor cell prior tumor biopsy specimen ) Chemotherapy , radiotherapy , anticancer immunotherapy , investigational agent within 4 week treatment day 1 ( 6 week previous regimen include mitomycin nitrosoureas ) . Prior epidermal growth factor receptortargeting therapy Known central nervous system ( CNS ) metastasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Advanced Colorectal Cancer</keyword>
	<keyword>Colorectal Carcinoma</keyword>
	<keyword>Colorectal Tumors</keyword>
	<keyword>Neoplasms , Colorectal</keyword>
</DOC>